STOK

Stoke Therapeutics Stock Analysis

AI Rating

Great
  • Quality8/10
  • Growth↑ 9/10
  • Momentum↑ 9/10
Stoke Therapeutics sales and earnings growth
STOK Growth
Great
  • Revenue Y/Y↑ 1128.17%
  • EPS Y/Y↑ 134.76%
  • FCF Y/Y↑ 161.83%
Stoke Therapeutics gross and profit margin trends
STOK Profitability
Good
  • Gross margin ↑ 100.00%
  • EPS margin↑ 19.70%
  • ROIC↑ 16.40%
Stoke Therapeutics net debt vs free cash flow
STOK Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ 2.1

Stoke Therapeutics stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗